Bi Xue-Ling, Xie Cai-Xia
First Ward of Department of Obstetrics and Gynecology, The Yan'an People's Hospital Third Ward of Department of Obstetrics and Gynecology, The Yan'an People's Hospital, Yan'an, China.
Medicine (Baltimore). 2018 Jun;97(26):e11266. doi: 10.1097/MD.0000000000011266.
This retrospective study evaluated the effect of neuromuscular electrical stimulation (NMES) for the treatment of endometriosis-associated pain (EAP).A total of 154 patients with EAP were included and were divided into 2 groups in this retrospective study. Eighty-three patients were assigned a treatment group, and underwent NMES therapy, while 71 subjects in the control group were at waiting list. The primary outcome of pain was measured by the numerical rating scale (NRS) and the Endometriosis Symptom Severity scale (ESSS). The secondary outcome was quality of life, measured by the 36-Item Short Form Health Survey (SF-36). All outcomes were measured before and after 5-week and 10-week treatment. Moreover, we also recorded the adverse events in this study.After 5-week treatment, no significant differences in all outcome measurements were found between the 2 groups. However, after 10-week treatment, NMES therapy exerted better outcomes in NRS (P = .02), ESSS (P = .04), and SF-36 [Physical Component Summary (PCS), P < .01; Mental Component Summary (MCS), P < .01], compared with the patients at the waiting list. Moreover, no significant differences of all adverse events were found between the 2 groups, although mild and acceptable adverse events occurred in the treatment group.This study demonstrated that NMES is effective for treating patients with EAP.
这项回顾性研究评估了神经肌肉电刺激(NMES)治疗子宫内膜异位症相关疼痛(EAP)的效果。在这项回顾性研究中,共纳入了154例EAP患者,并将其分为两组。83例患者被分配到治疗组,接受NMES治疗,而对照组的71名受试者则在等待名单上。疼痛的主要结局通过数字评分量表(NRS)和子宫内膜异位症症状严重程度量表(ESSS)进行测量。次要结局是生活质量,通过36项简短健康调查(SF-36)进行测量。所有结局均在5周和10周治疗前后进行测量。此外,我们还记录了本研究中的不良事件。5周治疗后,两组在所有结局测量方面均未发现显著差异。然而,10周治疗后,与等待名单上的患者相比,NMES治疗在NRS(P = 0.02)、ESSS(P = 0.04)和SF-36[身体成分总结(PCS),P < 0.01;心理成分总结(MCS),P < 0.01]方面取得了更好的结果。此外,两组之间在所有不良事件方面均未发现显著差异,尽管治疗组发生了轻度且可接受的不良事件。本研究表明,NMES对治疗EAP患者有效。